NeuroSense Therapeutics (NRSN) Total Current Liabilities (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Total Current Liabilities came in at $2.5 million in Q4 2025, up 26.31% year-over-year from $2.0 million in Q4 2024, and up 14.21% quarter-over-quarter from $2.2 million in Q2 2025.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Total Current Liabilities (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Total Current Liabilities across 6 years of filings, most recently posting $2.5 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 26.31% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (up 26.31% YoY), while the FY2025 annual figure was $2.5 million, up 26.31% from the prior year.
- Total Current Liabilities came in at $2.5 million for Q4 2025 at NeuroSense Therapeutics, up from $2.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $4.5 million in Q1 2024 to a low of $597000.0 in Q4 2021.
- Average Total Current Liabilities over 5 years is $2.3 million, with a median of $2.2 million recorded in 2025.
- Year-over-year, Total Current Liabilities soared 397.5% in 2021 and tumbled 42.41% in 2024.
- Over 5 years, Total Current Liabilities stood at $597000.0 in 2021, then soared by 189.11% to $1.7 million in 2022, then surged by 100.41% to $3.5 million in 2023, then plunged by 42.41% to $2.0 million in 2024, then gained by 26.31% to $2.5 million in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $2.5 million in Q4 2025, $2.2 million in Q2 2025, and $2.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 2.53 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 1.58 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 283.60 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | 2.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 4.54 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 2.81 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 811,000.00 |
| Jun 30, 2022 | 736,000.00 |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 597,000.00 |
| Dec 31, 2020 | 120,000.00 |
API Access
NeuroSense Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();